Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



The importance of estrogen-α and progesterone immunohistochemical staining expression in patients with papillary thyroid carcinoma

Betul Peker Cengiz.




Abstract
Cited by 0 Articles

General information: Papillary thyroid cancer is the most common type of endocrine malignancy in females, and it is approximately three times more common among females than males. Given that these lesions are more common in women than men and that the rate decreases after menopause, sex steroid hormones are thought to play a role in the etiology of the benign and malignant lesions of the thyroid.
Aim: Estrogen receptor-α (ERα) and Progesterone receptor (PR) were studied in 58 patients who were diagnosed as papillary thyroid carcinoma in our hospital between 2011 and 2013. ERα and PR expression patterns were compared according to age, sex, tumor subtype, metastasis, focality, and tumor size.
Methods: ERα and PR immunohistochemical staining were performed on a Ventana Benchmark XT device. More than 10% expression of ERα and PR immunohistochemical stains in the tumor field was considered positive.
Conclusion: The findings in our study support many studies in the literature, and there is a significant relationship between tumor size, tumor stage, and metastasis and ERα and PR immunohistochemical expression. However, more studies are still needed to evaluate the effect of ERα and PR on thyroid papillary cancers.

Key words: ERα, PR, thyroid, papillary cancer, immunohistochemistry.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.